NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Christina Annunziata
National Cancer Institute - Bethesda / United States
Others
AD Scientific Index ID: 4393039
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Christina Annunziata's MOST POPULAR ARTICLES
1-)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myelomaCM Annunziata, RE Davis, Y Demchenko, W Bellamy, A Gabrea, F Zhan, ...Cancer cell 12 (2), 115-130, 200710762007
2-)
Efficacy and safety of avelumab for patients with recurrent or refractory ovarian cancer: phase 1b results from the JAVELIN solid tumor trialML Disis, MH Taylor, K Kelly, JT Beck, M Gordon, KM Moore, MR Patel, ...JAMA oncology 5 (3), 393-401, 20193872019
3-)
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activityNS Azad, EM Posadas, VE Kwitkowski, SM Steinberg, L Jain, ...Journal of Clinical Oncology 26 (22), 3709-3714, 20083832008
4-)
Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guidelinePA Konstantinopoulos, B Norquist, C Lacchetti, D Armstrong, RN Grisham, ...Journal of Clinical Oncology 38 (11), 1222-1245, 20203662020
5-)
Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppressionCM Rice, LC Davies, JJ Subleski, N Maio, M Gonzalez-Cotto, C Andrews, ...Nature communications 9 (1), 5099, 20182842018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept